Does The Rare Disease EDS Plague Fibromyalgia? – February 23, 2018 – By Celeste Cooper
hEDS = EDS hypermobile type, previously known as EDS type III or joint hypermobility syndrome.
According to the National Organization for Rare Disorders (NORD), there are many Ehlers Danlos Syndromes and related disorders caused by different genetic defects in collagen. We will focus on the most common type of Ehlers-Danlos syndrome in this article.
this type of EDS can co-occur in fibromyalgia and myofascial pain syndrome even though it is thought to be a rare condition. Fibromyalgia and EDS also share connections you might not have considered. Continue reading
Executive function in chronic pain patients and healthy controls: Different cortical activation during response inhibition in fibromyalgia – free full-text /PMC3715316/ – Dec 2011
The primary symptom of fibromyalgia (FM) is chronic, widespread pain; however, patients report additional symptoms including decreased concentration and memory.
Performance based deficits are seen mainly in tests of working memory and executive function.
Neural correlates of executive function were investigated in 18 FM patients and 14 age-matched HCs during a simple go/no-go task (response inhibition) while they underwent functional magnetic resonance imaging (fMRI). Continue reading
Brain Changes May Explain Chronic Pain Symptoms in Different Disorders – August 23, 2017 In Fibromyalgia, News. by Patricia Inacio, PhD
Even though fibromyalgia and urological chronic pelvic pain syndrome (UCPPS) are different disorders, new research suggests that patients suffering from these conditions may actually share alterations to the brain, perhaps explaining why certain UCPPS patients exhibit fibromyalgia characteristics, such as widespread pain.
The study “Brain signature and functional impact of centralized pain: a multidisciplinary approach to the study of chronic pelvic pain (MAPP) network study” was published in the journal Pain. Continue reading
Is Fibromyalgia Making You Older? – Health Rising
Being in chronic pain is no fun, that’s for sure. Think of any area of your life – your work, your relationships, your mood, your finances – and see if chronic pain doesn’t impact it negatively. But is being in chronic pain itself dangerous? Some in the medical profession give chronic pain short shrift.
They assert that it’s the result of a false alarm from your central nervous system; i.e. while it’s uncomfortable, it doesn’t constitute a threat to you physiologically.
The pain in FM is certainly different from normal pain. Continue reading
Nighttime Opioid Combination to Treat Fibromyalgia With PTSD – Brandon May – September 07, 2017
Patients with PTSD may present with underlying and undiagnosed fibromyalgia, which contributes to poor sleep and further pain amplification.
“Persisting fibromyalgia can intensify associated fibrocytic symptoms resulting in worsening of the underlying primary condition, even if that primary condition is not pain associated”
Dr Figueroa recommends a nighttime administration of 50 mg tramadol and 4 to 8 mg tizanidine at 7 pm for patients with fibromyalgia and PTSD.
What? He’s recommending not only an opioid but also a muscle relaxant – together! Continue reading
Routine use of punch biopsy to diagnose small fiber neuropathy in fibromyalgia patients – Clin Rheumatol 2014 Dec – free full-text /PMC4348533/
Recent work has demonstrated that approximately 50 % of patients diagnosed with fibromyalgia have damage to their small unmyelinated nerve fibers
A skin punch biopsy is a sensitive and specific diagnostic test for this damage as a reduction in nerve fiber density allows for the diagnosis of small fiber neuropathy.
Small fiber neuropathy is a disease with symptoms similar to fibromyalgia, but it often has a definable etiology. Continue reading
Many Fibromyalgia Patients Have Small-Fiber Polyneuropathy – October 18, 2012 – medscape.com – Daniel M. Keller, PhD
In a small study of patients labeled as having fibromyalgia, almost half actually had small-fiber polyneuropathy (SFPN), a potentially treatable condition.
Dr. Oaklander noted that despite an emphasis on central mechanisms as the cause of fibromyalgia, these findings suggest that a specific — and sometimes treatable — type of peripheral neuropathy is a common cause of the condition.
It seems like quite a leap to assume the neuropathy is the *cause* of fibromyalgia. Another article from 4 years later (summarized below) suggests the opposite: that fibromyalgia is the cause of the peripheral neuropathy. Continue reading
Exercise Tests Suggest Autoimmunity Causes the Exertion Problems in Chronic Fatigue Syndrome, Fibromyalgia and POTS – Health Rising – by Cort Johnson | Aug 16, 2017
Researchers and doctors get interested in ME/CFS in different ways. Many have a personal connection, but for David Systrom, a pulmonologist, it was all about demand.
He didn’t seek chronic fatigue syndrome patients out – quite the contrary. When Systrom was given control of a clinical cardiopulmonary lab, he started doing invasive cardiopulmonary exercise tests (iCPET’s) on people with exercise intolerance.
Invasive Cardiopulmonary Exercise Testing (iCPET) Continue reading
Increased neural noise and impaired brain synchronization in fibromyalgia patients during cognitive interference | Scientific Reports | July 2017
Fibromyalgia (FM) and other chronic pain syndromes are associated with cognitive dysfunction and attentional deficits, but the neural basis of such alterations is poorly understood
Dyscognition may be related to high levels of neural noise, understood as increased random electrical fluctuations that impair neural communication; however, this hypothesis has not yet been tested in any chronic pain condition.
Here we compared electroencephalographic activity (EEG) in 18 FM patients -with high self-reported levels of cognitive dysfunction- and 22 controls during a cognitive control task. Continue reading
The Lyrica Effect: Lyrica Study Uncovers Key Brain Abnormalities in Fibromyalgia – Health Rising by Cort Johnson | Sep 30, 2013
Lyrica’s success – despite issues with side effects and efficacy in a significant number of fibromyalgia patients – highlights the tremendous need for drugs that relieve neuropathic pain.
Fifteen years in development, Lyrica was originally developed to reduce seizures by increasing GABA levels, but was later found to reduce glutamate, substance P and norepinephrine levels instead.
Researchers know the pharmacological effects Lyrica has, but they don’t know what parts of the brain it’s affecting. Continue reading